Pharmaceutical compositions of lithium compounds to treat presen

Details Pharmaceutical compositions of lithium compounds to treat presen Pharmaceutical compositions of lithium compounds to treat presen

1987-01-27

1988-06-28

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Radical -xh acid, or anhydride, acid halide or salt thereof...

514560, A61K 3120

Patent

active

047539640

ABSTRACT:
This invention relates to the treatment of presenile or sensile dementia and in particular to the treatment of Alzheimer's disease. It is proposed that such conditions may be combatted or their effects alleviated by the administration of a physiologically acceptable lithium compound and/or of an essential fatty acid or a physiologically acceptable salt thereof and there are described herein methods of treatment of such conditions.

REFERENCES:
patent: 4058594 (1977-11-01), Williams
patent: 4328243 (1982-05-01), Horrobin et al.
Mammalian Pathol. Biochem., vol. 103, 1985, Abstract No. 212685x, Chemical Abstracts 103.
Chemical Abstracts, vol. 96, 1982, Abstract No. 210912g, Chemical Abstracts 96.
Havens and Cole, J. Clin. Psychopharmacol., 2, (1982), 71-72.
Biological Psychiatry, vol. 19, No. 2, 1984-Lithium-Induced Increases in Red Blood Cell Choline and Memory Performance in Alzheimer-Type Dementia, Samuel D. Brinkman et al.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions of lithium compounds to treat presen does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions of lithium compounds to treat presen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions of lithium compounds to treat presen will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1914985